JD Health International Secures Shareholder Approval at AGM

An update from JD Health International, Inc. ( (HK:6618) ) is now available.

JD Health International, Inc. announced the successful passing of all proposed resolutions at its Annual General Meeting held on June 20, 2025. The resolutions included the adoption of financial statements, re-election of directors, and granting of mandates for share issuance and repurchase. This outcome reflects strong shareholder support and positions the company for continued strategic initiatives and governance stability.

The most recent analyst rating on (HK:6618) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.

More about JD Health International, Inc.

JD Health International, Inc. operates in the healthcare industry, focusing on providing online healthcare services and products. The company is known for its digital health platform, which offers telemedicine, online pharmacy, and health management services, catering primarily to the Chinese market.

Average Trading Volume: 12,891,475

Technical Sentiment Signal: Hold

Current Market Cap: HK$133.1B

For detailed information about 6618 stock, go to TipRanks’ Stock Analysis page.